ACRV   $6.55  1.71% Market Closed After Close 6.55 0.0

Acrivon Therapeutics Inc
Total Cash 180.54M
totalCashPerShare 5.829
EBITDA -75.56M
Total Debt 4.22M
quickRatio 15.999
currentRatio 16.161
Total Revenue
debtToEquity 1.954
Revenue/Share
ROA -0.24414
ROE -0.37784
grossProfits
freeCashflow -31.31M
operatingCashflow -53.16M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 71.46M
forwardPE -2.948148
floatShares 11.22M
sharesOutstanding 30.97M
sharesShort 1.11M
sharesShortPriorMonth 1.28M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.76%
Short Ratio help_outline 7.93%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 6.977
Price To Book help_outline 1.14
earningsQuarterlyGrowth
netIncomeToCommon -69.00M
trailingEps -2.72%
forwardEps -2.70%
enterpriseToEbitda -0.95
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 81
lastUpdated Nov. 1, 2024, 10:23 p.m.